Aravax secures US$20 million Series B funding for peanut allergy therapy
Aravax’s novel platform technology has potential application against other allergens.
Elise Shaw
Ex-Digital Editor at Forbes Australia.
FairSupply ESG Saas platform backed with $6.3 million Series A round
FairSupply provides corporate and institutional clients with visibility over ESG risk in supply chains and investment portfolios.
Australian researchers discover bacterial mechanism that confers a survival tactic putting patient lives at risk
Golden Staph is one of the major infectious diseases threatening hospitals in Australia.
How technology can help you understand your biological rhythms
It is so valuable to put the power of people’s own health data and their health outcomes into their own hands.
Latest move into VC funds for HNWI
Funds aims to bring world-class investment opportunities to Australian HNWI.
Central banks and inflation key to bringing investors back into fixed income markets
Bond yields are also now at very attractive levels – the 10-year UST is at its highest rate since 2008.
How Love Island can make you a must-have item
We essentially want to be able to fill the suitcase so when a man goes away, his whole suitcase is full of Vacay.
Froth and bubble to normalise for venture capital startup investment
Deaker thinks the current climate could lead to enormous creativity across sectors and industry in 2023.
Fixed income yields may be dangerous to ignore
How much more tightening is required by central banks to achieve control over inflation?
BiomeBank to scale up with $10.65 million capital raise
BiomeBank is aiming to treat and prevent disease by restoring gut microbial ecology.